# IMCgp100 in Advanced Unresectable Melanoma

> **NCT01209676** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 1 (actual)

## Conditions studied

- Melanoma
- Advanced Disease
- Unresectable

## Interventions

- **DRUG:** IMCgp100 injection

## Key facts

- **NCT ID:** NCT01209676
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-03
- **Final completion:** —
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2016-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01209676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01209676, "IMCgp100 in Advanced Unresectable Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01209676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*